Different diagnostic imaging modalities bring unique tools to the table when it comes to generating images of the heart, including 2D, 3D and even 4D images generated by ultrasound devices. C-arms and other modalities also continue to be useful for medical imaging of the heart.
“Cardiovascular diseases (CVD) are the most common causes of patient hospitalization and mortality in many developed nations. It continues to be the leading cause of death worldwide as well. It is imperative for a physician to perform a cardiovascular imaging test to diagnose heart condition and during subsequent management of any cardiac disorder,” according to Transparency Market Research. “Cardiovascular imaging (CV imaging) enables radiologist to see inside the body and shows the structure of heart in great detail. The physician can understand blood flow within the body and diagnose a patient’s heart or vascular condition. The global market for cardiovascular imaging is expected to grow in the near future owing to the increasing demand from the emerging economies in the Asia-
Pacific and rest of the world. Moreover, the increasing dependence on imaging modalities have increased the adoption of imaging informatics which is expected to witness far-reaching positive impact on the global CV imaging and informatics market.”
“Echocardiography, angiography, nuclear cardiac imaging, computed tomography, cardiac positron emission tomography (cardiac PET) and cardiac magnetic resonance imaging (cardiac MRI) are the most common imaging modalities used for diagnosis and interventional cardiology,” according to Transparency Market Research.
“Echocardiography imaging is an optional ultrasound method of cardiac imaging and includes transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), stress echocardiography,” according to Transparency Market Research. “Recently, 3D echocardiography is being used for cardiovascular imaging which is non-invasive, easy to operate, and produces a much clearer image. Nuclear cardiac imaging is becoming a popular method which involves usage of a radionuclide – technetium Tc 99m sestamibi (MIBI). This non-invasive cardiac imaging method is considered to be one of the best methods to evaluate and diagnose a heart attack. It is also a very handy technique to assess myocardial salvage among patients with acute myocardial infarction (MI). The market for non-invasive cardiovascular imaging is expected to grow rapidly in the coming years as the invasive imaging causes great inconvenience to the patients. Moreover, the non-invasive imaging is less costly and incurs comparatively lesser hospitalization to the patient.”
Market Research Future predicts growth in the cardiac imaging software market based on health care trends.
“The cardiac imaging software market growth is majorly attributed to increasing prevalence of heart diseases and diabetes. Cardiovascular diseases are one of the major reasons for heart diseases. According to the WHO, over 422 million people across the globe are suffering from diabetes. An increasing number of patients suffering from diabetes and other cardiovascular disease will fuel the growth of the market,” Market Research Future reports.
“Many government organizations and private companies are providing funds to the cardiac imaging software developers to improve its features. Increasing government support, increasing applications of computer-aided diagnosis and development of healthcare IT in health care industries will provide a push to the growth of the market. However, the manufacturers have to follow strict regulatory rules which may slow the growth of the market.”
The global cardiac imaging software market is expected to grow at a CAGR of about 9 percent during the forecast period 2017-2023, according to Market Research Future.
Technavio, a market research company with global coverage, has prepared several reports on medical imaging and expects the global medical imaging market to exceed $37 billion by 2020, according to the research firm’s website.
One Technavio market research analyst predicts that the global market for medical imaging will grow at a compound annual growth rate (CAGR) of nearly five percent by 2020, according to the research company’s website.